Cargando…
COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
The coronavirus disease 2019 (COVID-19) pandemic is an ongoing global health crisis causing major challenges for clinical care in patients with gastrointestinal diseases. Although triggering of anti-viral immune responses is essential for clearance of infection, some patients have severe lung inflam...
Autor principal: | Neurath, Markus F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239481/ https://www.ncbi.nlm.nih.gov/pubmed/34188251 http://dx.doi.org/10.1038/s41575-021-00480-y |
Ejemplares similares
-
Gastroenterology and hepatology /
Publicado: (1999) -
Metabonomics in Gastroenterology and Hepatology
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2019) -
Editorial: Systems Biology and Bioinformatics in Gastroenterology and Hepatology
por: Jansen, Peter L. M., et al.
Publicado: (2019) -
COVID‐19 in gastroenterology and hepatology: Where will we be?
por: Lantinga, Marten A., et al.
Publicado: (2021) -
COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered
por: Liu, Shao, et al.
Publicado: (2021)